Blogs

Pages

Nurse prepares vaccine at Bwaila Hospital, Lilongwe, Malawi

Reducing Health Risks and Building Trust: Pharmacovigilance During COVID-19 and Beyond

September 15, 2020

Medicines cure but can harm patients too. Countries must have pharmacovigilance systems in place to ensure that medicines are safe, effective, of good quality, and used appropriately.

View Item

Moving LMICs toward Self-Reliance: A Roadmap for Systematic Priority Setting for Resource Allocation

September 14, 2020

A Roadmap for Systematic Priority Setting and Health Technology Assessment (HTA) serves as a practical guide for policy action in LMICs to successfully implement HTA and put countries on the path toward UHC and self-reliance.

View Item
Mom and baby receiving a prescription. Photo credit Jane Briggs

A Call for Strong Pharmaceutical Systems to Prevent Pneumonia Deaths in Children

November 11, 2020

By Jane Briggs, Senior Principal Technical Advisor and MNCH Lead, MTaPS

Pneumonia is the leading cause of death in children under age five worldwide, according to WHO. The disease claimed the lives of more than 800,000 children under the age of five last year—one child every 39 seconds (UNICEF).   

View Item

Who Gets What and Why? An op-ed makes the case for health technology assessments

October 20, 2020

In an opinion piece for Think Global Health—an initiative from the Council on Foreign Relations—MSH’s Global Lead of Infectious Diseases, Health Financing, Technologies, Data, and Impact, Dr. Héctor Castro, discusses the need for health technology assessment to set priorities and allocate precious resources.

View Item

MTaPS Experts Unpack the Benefits of the Game-Changing WHO Global Benchmarking Tool

August 17, 2020

To support countries in strengthening their regulatory capacity, WHO developed a framework for measuring and improving regulatory systems - the Global Benchmarking Tool (GBT).

View Item
A health care worker demonstrating how to perform hand washing at the facility. Photo credit: Daniel Paul

Making Infection Prevention Capacity Sustainable: A Six-Point Plan in Tanzania

August 4, 2020

By Dr. Doris Lutkam, MTaPS Senior Technical Advisor 

View Item
Participants develop an IPC policy statement during a training at Outspan Teaching and Referral Hospital, Nyeri County. (Photo: Doris Bota, MTaPS)

Containing Antimicrobial Resistance: Kenya’s Systems Approach

July 29, 2020

By Ndinda Kusu, Country Project Director, MTaPS Kenya

Antimicrobial resistance (AMR) is a dire problem in Kenya. There are already high levels of resistance to common first-line drugs and rising infections from life-threatening pathogens, including those leading to pneumonia, salmonella, and gonorrhoea. 

View Item
banner image - photo credit Jiro Ose

Regulating COVID-19 Medical Products: An Urgent Need

July 2, 2020

he USAID MTaPS Program is harnessing its regulatory systems strengthening expertise to support low- and middle-income countries in ensuring that COVID-19 medical products meet regulatory standards and save lives as intended.

View Item
laptop projecting a graph

A Conversation with MTaPS Monitoring, Evaluation and Learning Director Francis Okello

June 9, 2020

You have been working in M&E for well over two decades. What are the top two or three ways the field has progressed since you began work?

View Item

Promoting Appropriate Use of Medicines Critical to an Effective COVID-19 Response

June 1, 2020

A pandemic is the ultimate challenge to the efficacy and resiliency of many systems, including the pharmaceutical system—how medicines and other medical products are managed in health systems.

View Item

Pages

Subscribe to Blogs